DRW Securities’s Cardio Diagnostics CDIO Stock Holding History

DRW Securities’s Portfolio CDIO Stock Details CDIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-40,463	Closed	-$110K	–	1339
2025 Q4	$110K	Buy	40,463 +22,298	+123%	+$81.1K	﹤0.01%	1057
2025 Q3	$72.8K	Buy	+18,165	New	+$71.7K	﹤0.01%	1208

Other funds holding CDIO

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

SRL

Scientech Research LLC Jersey City, New Jersey $120M AUM 73.62% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

VFT

Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM

TRCT

Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

DRW Securities's CDIO Position: Q1 2026 in Review

DRW Securities sold out of Cardio Diagnostics (CDIO) in Q1 2026, closing a stake of 40,463 shares — an estimated $110K sold.

DRW Securities first reported a position in CDIO in Q3 2025 and held it in 2 quarters. The position peaked at $110K in Q4 2025. 16 funds tracked by Wall St. Rank hold CDIO as of Q1 2026.

DRW Securities reported no remaining Cardio Diagnostics position as of Q1 2026 after selling out during the quarter.
DRW Securities sold 40,463 Cardio Diagnostics shares in Q1 2026, an estimated $110K.
DRW Securities first reported a position in Cardio Diagnostics in Q3 2025 and held it in 2 quarters.
DRW Securities's Cardio Diagnostics position peaked at $110K in Q4 2025.
16 funds tracked by Wall St. Rank held Cardio Diagnostics as of Q1 2026.

Based on DRW Securities's 13F filing for Q1 2026, filed 13 May 2026.